Volume 124, Issue 2 pp. E20-E26
Laryngology

Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: A pilot study

Emily K. Plowman PhD

Corresponding Author

Emily K. Plowman PhD

Department of Communication Sciences and Disorders, University of South Florida, Tampa, Florida

correspondence to Emily K. Plowman, PhD, Assistant Professor, Communication Sciences and Disorders, University of South Florida, 4202 E. Fowler Ave., PCD 1017, Tampa, FL 33620. E-mail: [email protected]Search for more papers by this author
Khadijeh Bijangi-Vishehsaraei PhD

Khadijeh Bijangi-Vishehsaraei PhD

Department of Otolaryngology–Head and Neck Surgery, Indiana University, Indianapolis, Indiana

Search for more papers by this author
Stacey Halum MD

Stacey Halum MD

Department of Otolaryngology–Head and Neck Surgery, Indiana University, Indianapolis, Indiana

Search for more papers by this author
Daniel Cates MD

Daniel Cates MD

Department of Otolaryngology–Head and Neck Surgery, University of California, Davis, Davis, California

Search for more papers by this author
Helmut Hanenberg PhD

Helmut Hanenberg PhD

Department of Otolaryngology–Head and Neck Surgery, Indiana University, Indianapolis, Indiana

Search for more papers by this author
Amanda S. Domer MS

Amanda S. Domer MS

Department of Communication Sciences and Disorders, University of South Florida, Tampa, Florida

Search for more papers by this author
Jan A. Nolta PhD

Jan A. Nolta PhD

Stem Cell Program, Department of Internal Medicine, University of California, Davis, Davis, California

Search for more papers by this author
Peter C. Belafsky MPH, PhD, MD

Peter C. Belafsky MPH, PhD, MD

Department of Otolaryngology–Head and Neck Surgery, University of California, Davis, Davis, California

Search for more papers by this author
First published: 08 August 2013
Citations: 20

The authors have no funding, financial relationships, or conflicts of interest to disclose.

Abstract

Objectives/Hypothesis

Autologous muscle-derived stem cell (MdSC) therapy is a promising treatment to restore function. No group has evaluated MdSC therapy in a denervated tongue model. The purpose of this pilot investigation was to determine the extent of autologous MdSC survival, effects on tongue muscle atrophy, maximal contractile force, and lingual pressure in a denervated ovine tongue model.

Study Design

Pilot animal experiment.

Methods

Bilateral implantable cuff electrodes were placed around the hypoglossal nerves in two Dorper cross ewes. Tensometer and high-resolution manometry (HRM) testing were performed during supermaximum hypoglossal nerve stimulation to assess baseline tongue strength. Sternocleidomastoid muscle biopsies were acquired to create autologous MdSC cultures. At 1 month, 5 × 108 green fluorescent protein (GFP)-labeled autologous MdSCs were injected into the partially denervated tongue. Two-months postinjection, lingual tensometer testing, HRM, and postmortem histological assessment were performed.

Results

GFP+ myofibers were identified in denervated tongue specimens indicating MdSC survival. Muscle fiber diameter was larger in GFP+ fibers for both tongue specimens, suggesting attenuation of muscle atrophy. Myofiber diameter was larger in GFP+ myofibers than preinjury diameters, providing evidence of new muscle formation. These myogenic changes led to a 27% increase in maximal tongue contractile force and a 54% increase in maximum base of tongue pressure in one animal.

Conclusions

Autologous MdSC therapy may be a viable treatment for the partially denervated tongue, with current findings demonstrating that injected MdSCs survived and fused with tongue myofibers, with a resultant increase in myofiber diameter and an increase in tongue strength.

Level of Evidence

N/A. Laryngoscope, 124:E20–E26, 2014

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.